Home > Healthcare > Medical Devices > Diagnostic Devices > rabies diagnostics market
Get a free sample of Rabies Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Rabies Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Rabies Diagnostics Market size was valued at around USD 1.8 billion in 2023 and is estimated to grow at 4.7% CAGR from 2024 to 2032. The rising cases of animal bites, coupled with favorable government policies, are significantly driving the growth of the market.
An increase in animal bite incidents, particularly from stray dogs, increases the need for animal diagnostics and heightened the need for effective and rapid diagnostic solutions to prevent the spread of rabies. Governments worldwide are implementing policies and programs to address this issue. For instance, World Health Organization (WHO), in collaboration with multiples partners, launched the "United Against Rabies" initiative in 2020, which aims to accelerate efforts to eradicate rabies through widespread dog vaccination and enhanced human treatment protocols.
Additionally, regulatory support for the development and deployment of advanced diagnostic tools is fostering market growth. These combined efforts not only aim to reduce rabies incidence but also ensure timely diagnosis and treatment, thereby propelling the demand for rabies diagnostic market.
Rabies diagnostics refer to the methods and techniques used to detect and confirm the presence of rabies virus in animals and humans. These diagnostics are essential for the accurate identification of rabies infection, which is critical for timely treatment and prevention measures.
Rabies diagnostics industry size was USD 1.8 billion in 2023 and is projected to expand at 4.7% CAGR from 2024 to 2032, due to the rising cases of animal bites, coupled with favorable government policies.
The fluorescent antibody test (FAT) segment in the rabies diagnostics industry accounted for USD 503.1 million in 2023 and is estimated to grow at significant CAGR from 2024 to 2032, owing to its reliability, accuracy, and long history of use.
The ELISA technology segment in the rabies diagnostics industry is projected to record USD 911.3 million by 2032, due to their high sensitivity and specificity in detecting antibodies or antigens related to the rabies virus.
North America rabies diagnostics industry amassed USD 765.8 million in revenue in 2023 and is projected to depict substantial gains from 2024 to 2032, led by the growing prevalence of rabies in the region.